Anti-VEGF vs Photodynamic Therapy for Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Anti-VEGF Therapy Versus Photodynamic Therapy in the Treatment of Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy
Retina (Philadelphia, Pa.) 2017 Jul 07;[EPub Ahead of Print], E Peiretti, G Caminiti, R Serra, L Querques, R Pertile, G QuerquesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.